1. Home
  2. VRME vs PMCB Comparison

VRME vs PMCB Comparison

Compare VRME & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

BUY

Current Price

$0.97

Market Cap

8.4M

Sector

Technology

ML Signal

BUY

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.81

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
PMCB
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
PMCB
Price
$0.97
$0.81
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
9.9M
703.8K
Earning Date
11-14-2025
12-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.63
52 Week High
$5.00
$1.90

Technical Indicators

Market Signals
Indicator
VRME
PMCB
Relative Strength Index (RSI) 63.01 50.28
Support Level $0.59 $0.68
Resistance Level $1.41 $0.78
Average True Range (ATR) 0.09 0.08
MACD 0.05 -0.00
Stochastic Oscillator 46.64 55.45

Price Performance

Historical Comparison
VRME
PMCB

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: